Effect of Fms-like tyrosine kinase 3 (FLT3) ligand (FL) on antitumor activity of gilteritinib, a FLT3 inhibitor, in mice xenografted with FL-overexpressing cells
Tatsuya Kawase(Astellas Pharma (Japan)), Taku Yoshida(Sapporo Medical University)
Cited by 83
Related Papers
Targeting Akt3 Signaling in Triple-Negative Breast Cancer
|Cancer Research|2013|155
CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer
|Cancer Research|2015|109